• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Celgene Corporation (CELG) - Financial and Strategic SWOT Analysis Review

  • ID: 1292009
  • March 2015
  • 74 pages
  • GlobalData

FEATURED COMPANIES

  • Amgen Inc.
  • Eisai Co., Ltd.
  • Genta Incorporated
  • Merck & Co., Inc.
  • Shire Plc
  • MORE

Celgene Corporation (CELG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by The publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amgen Inc.
  • Eisai Co., Ltd.
  • Genta Incorporated
  • Merck & Co., Inc.
  • Shire Plc
  • MORE

List of Tables
List of Figures
Section 1 - About the Company
Celgene Corporation - Key Facts
Celgene Corporation - Key Employees
Celgene Corporation - Key Employee Biographies
Celgene Corporation - Major Products and Services
Celgene Corporation - Pharmaceutical Pipeline Products Data
Celgene Corporation, Pipeline Products by Therapy Area
Celgene Corporation, Pipeline Products by Development Phase
Celgene Corporation - History
Celgene Corporation - Company Statement
Celgene Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Celgene Corporation - Business Description
Celgene Corporation - Corporate Strategy
Celgene Corporation - SWOT Analysis
SWOT Analysis - Overview
Celgene Corporation - Strengths
Strength - Consistent Financial Performance
Strength - Focused Research and Development Activities
Strength - Strong Presence - Multiple Myeloma Market
Celgene Corporation - Weaknesses
Weakness - Clinical Discontinuation
Weakness - Imnovid - Birth Defects Risks
Celgene Corporation - Opportunities
Opportunity - Market Potential: Oncology
Opportunity - Product Pipeline
Opportunity - Alliances & Partnerships
Celgene Corporation - Threats
Threat - Litigations and Legal Issues
Threat - Highly Competitive Industry
Threat - Stringent Government Regulations
Celgene Corporation - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Celgene Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Celgene Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Celgene Corporation, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 02, 2015: Celgene Gift to UAMS Myeloma Institute for Bart Barlogie Center for Molecular Diagnostics Advances the Course of Human Health for Patients with Multiple Myeloma
Feb 25, 2015: Celgene Encourages Psoriatic Arthritis Patients to pSAY YES! a Different Approach to Disease Management
Jan 29, 2015: Celgene Reports Fourth Quarter and Full Year 2014 Operating and Financial Results
Jan 12, 2015: Celgene Announces 2015 and Long-Term Financial Outlook and Preliminary 2014 Results
Dec 18, 2014: Celgene Earns CEO Cancer Gold Standard Accreditation
Nov 13, 2014: Global Survey Finds That Pancreatic Cancer, a Leading Cause of Cancer Deaths, is Virtually Unknown by Many in Europe and US
Oct 23, 2014: Celgene Reports Third Quarter 2014 Operating and Financial Results
Sep 19, 2014: Celgene Appoints Tuomo Patsi as President of EMEA and Commits to Continue Delivering Innovative Solutions to Meet Patient Needs Across the Region
Jul 24, 2014: Celgene Reports Second Quarter 2014 Operating and Financial Results
Jun 26, 2014: Celgene Mourns the Passing of Board of Director Member, Rodman L. Drake
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
Celgene Corporation, Key Facts
Celgene Corporation, Key Employees
Celgene Corporation, Key Employee Biographies
Celgene Corporation, Major Products and Services
Celgene Corporation, Number of Pipeline Products by Therapy Area
Celgene Corporation, Number of Pipeline Products by Development Stage
Celgene Corporation, Pipeline Products By Therapy Area and Development Phase
Celgene Corporation, History
Celgene Corporation, Other Locations
Celgene Corporation, Subsidiaries
Celgene Corporation, Key Competitors
Celgene Corporation, Ratios based on current share price
Celgene Corporation, Annual Ratios
Celgene Corporation, Interim Ratios
Celgene Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Celgene Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Celgene Corporation, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Celgene Corporation, Pipeline Products by Therapy Area
Celgene Corporation, Pipeline Products by Development Phase
Celgene Corporation, Performance Chart (2010 - 2014)
Celgene Corporation, Ratio Charts
Celgene Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Celgene Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015

Note: Product cover images may vary from those shown

Eisai Co., Ltd.
Takeda Pharmaceutical Company Limited
Amgen Inc.
Shire Plc
Pharmaceutical Product Development, Inc.
Merck & Co., Inc.
Bristol-Myers Squibb Company
Genta Incorporated

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Grifols, S.A. Takeda Pharmaceutical Company Limited Alexion Pharmaceuticals Teva Pharmaceutical Industries Ltd. Endo International Plc. Essilor International S.A.